E. Lebacq
Impact in
- Microbiology top 5%
- Bacterial Infections and Vaccines
- Hepatology top 10%
- Hepatitis Viruses Studies and Epidemiology
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacology and Obesity Treatment 2
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Jan Poolman (1 shared paper)Gudrun Maechler (1 shared paper)Lars Østergaard (1 shared paper)Dominique Boutriau (1 shared paper)Christian Van Hoecke (2 shared papers)Jiřı́ Beran (2 shared papers)Béatrice De Vos (1 shared paper)Aino Karvonen (1 shared paper)
- Journals
- Vaccine (2 papers)Clinical Infectious Diseases (1 paper)International Archives of Allergy and Immunology (1 paper)The Lancet (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
E. Lebacq
13 papers receiving 328 citations
Peers
Comparison fields: 5 of 61
- Microbiology 80
- Hepatology 78
- Infectious Diseases 174
- Parasitology 35
- Animal Science and Zoology 46
Countries citing papers authored by E. Lebacq
This map shows the geographic impact of E. Lebacq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lebacq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lebacq more than expected).
Fields of papers citing papers by E. Lebacq
This network shows the impact of papers produced by E. Lebacq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lebacq. The network helps show where E. Lebacq may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lebacq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 112 | |
| 2 | 2008 | 78 | |
| 3 | 1999 | 35 | |
| 4 | 1967 | 27 | |
| 5 | 1998 | 25 | |
| 6 | 2001 | 23 | |
| 7 | 1995 | 18 | |
| 8 | 2002 | 12 | |
| 9 | 1990 | 10 | |
| 10 | 1971 | 5 | |
| 11 | 1993 | 3 | |
| 12 | Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis. | 1994 | 2 |
| 13 | Relative bioavailability of carbinoxamine and phenylpropanolamine from a retard suspension after single dose administration in healthy subjects. | 1992 | 1 |
About E. Lebacq
E. Lebacq is a scholar working on Pharmacology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 13 papers that have together received 351 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Pharmacology and Obesity Treatment (2 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Allergic Rhinitis and Sensitization (1 paper) and Heart Failure Treatment and Management (1 paper). The work is most often cited by research in Microbiology (80 citations), Hepatology (78 citations), Infectious Diseases (174 citations), Parasitology (35 citations) and Animal Science and Zoology (46 citations). E. Lebacq has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Jan Poolman, Gudrun Maechler, Lars Østergaard, Dominique Boutriau, Christian Van Hoecke, Jiřı́ Beran, Béatrice De Vos, Aino Karvonen, Johannes Förster and A. Delem. Their work appears in journals such as Vaccine, Clinical Infectious Diseases, International Archives of Allergy and Immunology, The Lancet and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.